World’s First Oral Pill To Treat COVID-19 Approved By Britain
Please Subscribe and Get Daily Updates in Your Inbox!!!
♦ The antiviral molnupiravir has been found to be safe and effective in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19 who are at elevated risk of developing the condition, according to the Medicines and Healthcare Products Regulatory Agency (MHRA).
♦ Ridgeback Biotherapeutics and Merck collaborated on the pill, which works by interfering with the virus’ replication.
♦ This stops it from growing, keeping viral levels low in the body and so minimizing disease severity, according to the Medicines and Healthcare Products Regulatory Agency of the United Kingdom.
♦ It can also be given outside of a hospital setting.